Seonghwan Seo
Korea Advanced Institute of Science and Technology (KAIST)
I am a Ph.D. student in the Department of Chemistry, KAIST, under the supervision of Prof. Woo Youn Kim.
My research area is AI-driven drug discovery, focusing on deep generative models for molecular design and in silico evaluation. During my Ph.D., I have specialized in integrating RL agents with autonomous laboratories to accelerate the discovery cycle.
More recently, I served as the engineering lead of Team KAIST for biomolecular structure prediction, developing AtlasFold for proteins and K-Fold for general biomolecular complexes. I am also extending my research into computational protein design, collaborating with Prof. Wengong Jin.
research highlights
Biomolecular structure prediction
- Biomolecular structure prediction: AtlasFold (bioRxiv 2026), K-Fold (bioRxiv 2026)
Generative modeling
- Generative flow networks (GFlowNets): TacoGFN (TMLR 2024), CGFlow (ICML 2025)
- Synthesis-oriented molecular design: BBAR (Advanced Science 2023), RxnFlow (ICLR 2025), HSX (bioRxiv 2026)
- Multi-state protein design: AF3-MSD/AF3-Cluster (ICLR 2026 GEM Workshop)
In silico evaluation
- Protein-based pharmacophore modeling: PharmacoNet (Chemical Science 2024)
- Drug-likeness scoring: Unsupervised drug-likeness (Chemical Science 2022)
- Enzyme-substrate specificity prediction: Boltz2ESI (ICLR 2026 GEM Workshop)
news
| Oct 26, 2026 | Our K-Fold preprint, “Predicting conformational changes induced by biomolecular interactions,” is now available on bioRxiv. Code: K-Fold. |
|---|---|
| Oct 01, 2026 | Our preprint on synthesis-aware generative design in trillion-scale chemical spaces for automated drug discovery is now available on bioRxiv. Code: RxnFlow. |
| Jul 10, 2026 | I organized a workshop on “The 2026 workshop on Generative AI and Agentic AI for Biology” (GenBio) at ICML 2026, Seoul, Korea. |
| Mar 02, 2026 | 2 papers are accepted on ICLR 2026 GEM Workshop: Boltz2ESi and AF3-MSD/AF3-Cluster. |
| May 02, 2025 | 1 paper is accepted to ICML 2025: CGFlow |